Benzoin schiff bases: Design, synthesis, and biological evaluation as potential antitumor agents

Dima A. Sabbah, Fatima Al-Tarawneh, Wamidh H. Talib, Kamal Sweidan, Sanaa K. Bardaweel, Eveen Al-Shalabi, Haizhen Andrew Zhong, Ghassan Abu Sheikha, Reema Abu Khalaf, Mohammad S. Mubarak

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background: Phosphoinositide 3-kinase α (PI3Kα) is an attractive target for anticancer drug design. Objectives: Target compounds were designed to probe the significance of alcohol and imine moieties tailored on a benzoin scaffold to better understand the structure activity relation (SAR) and improve their biological activity as anticancer compounds. Methods: Chemical synthesis of the targeted compounds, biological evaluation tests against human colon adenocarcinoma (HCT-116), breast adenocarcinoma (MCF-7), and breast carcinoma (T47D) cell lines, as well as Glide docking studies were employed in this investigation. Results: A new series of 1,2-diphenylimino ethanol was successfully synthesized and characterized by means of FT-IR, HRMS, NMR, and by elemental analysis. Biological screening revealed that the newly synthesized compounds inhibit PI3Kα activity in human colon adenocarcinoma (HCT-116), breast adenocarcinoma (MCF-7), and breast carcinoma (T47D) cell lines. Results additionally showed that these compounds exhibit selective antiproliferative activity, induce apoptosis, and suppress the VEGF production. Compounds 2b, 2d, and 2g displayed promising inhibitory activity in HCT-116 suggesting that hydrophobic and/or hydrogen bond-acceptor mediate(s) ligand-receptor interaction on o-and m-positions. Furthermore, compounds 2g, 2i, 2j, and 2h, bearing hydrophobic moiety on m-and p-position, exerted high antiproliferative activity in T47D and MCF-7 cells, whereas compound 2e showed selectivity against T47D and MCF-7. Molecular docking studies against PI3Kα and caspase-3 demonstrated a strong correlation between the predicted binding affinity (∆Gobsd) and IC50 values of prepared compounds for the caspase-3 model, implying that the cellulous inhibitory activity was caspase-3-dependent. Moreover, Glide docking against PI3Kα identified Ser774, Lys802, E849, V851, and Asp933 as key binding residues. Conclusion: The series exerted a potential PI3Kα inhibitory activity in human carcinoma cell lines expressing PI3Kα.

Original languageEnglish (US)
Pages (from-to)695-708
Number of pages14
JournalMedicinal Chemistry
Volume14
Issue number7
DOIs
StatePublished - Jan 1 2018

Fingerprint

Benzoin
1-Phosphatidylinositol 4-Kinase
Schiff Bases
Antineoplastic Agents
Adenocarcinoma
Caspase 3
Human Activities
Cell Line
Colon
Breast
Breast Neoplasms
Imines
Drug Design
MCF-7 Cells
Vascular Endothelial Growth Factor A
Inhibitory Concentration 50
Hydrogen
Ethanol
Alcohols
Apoptosis

Keywords

  • 1,2-diphenylimino ethanol
  • Angiogenesis
  • Caspase-3
  • Glide docking
  • HCT-116
  • MCF-7
  • PI3Kα
  • T47D

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Sabbah, D. A., Al-Tarawneh, F., Talib, W. H., Sweidan, K., Bardaweel, S. K., Al-Shalabi, E., ... Mubarak, M. S. (2018). Benzoin schiff bases: Design, synthesis, and biological evaluation as potential antitumor agents. Medicinal Chemistry, 14(7), 695-708. https://doi.org/10.2174/1573406414666180412160142

Benzoin schiff bases : Design, synthesis, and biological evaluation as potential antitumor agents. / Sabbah, Dima A.; Al-Tarawneh, Fatima; Talib, Wamidh H.; Sweidan, Kamal; Bardaweel, Sanaa K.; Al-Shalabi, Eveen; Zhong, Haizhen Andrew; Sheikha, Ghassan Abu; Khalaf, Reema Abu; Mubarak, Mohammad S.

In: Medicinal Chemistry, Vol. 14, No. 7, 01.01.2018, p. 695-708.

Research output: Contribution to journalArticle

Sabbah, DA, Al-Tarawneh, F, Talib, WH, Sweidan, K, Bardaweel, SK, Al-Shalabi, E, Zhong, HA, Sheikha, GA, Khalaf, RA & Mubarak, MS 2018, 'Benzoin schiff bases: Design, synthesis, and biological evaluation as potential antitumor agents', Medicinal Chemistry, vol. 14, no. 7, pp. 695-708. https://doi.org/10.2174/1573406414666180412160142
Sabbah DA, Al-Tarawneh F, Talib WH, Sweidan K, Bardaweel SK, Al-Shalabi E et al. Benzoin schiff bases: Design, synthesis, and biological evaluation as potential antitumor agents. Medicinal Chemistry. 2018 Jan 1;14(7):695-708. https://doi.org/10.2174/1573406414666180412160142
Sabbah, Dima A. ; Al-Tarawneh, Fatima ; Talib, Wamidh H. ; Sweidan, Kamal ; Bardaweel, Sanaa K. ; Al-Shalabi, Eveen ; Zhong, Haizhen Andrew ; Sheikha, Ghassan Abu ; Khalaf, Reema Abu ; Mubarak, Mohammad S. / Benzoin schiff bases : Design, synthesis, and biological evaluation as potential antitumor agents. In: Medicinal Chemistry. 2018 ; Vol. 14, No. 7. pp. 695-708.
@article{422be058ff434d25b6a3d6773ba11807,
title = "Benzoin schiff bases: Design, synthesis, and biological evaluation as potential antitumor agents",
abstract = "Background: Phosphoinositide 3-kinase α (PI3Kα) is an attractive target for anticancer drug design. Objectives: Target compounds were designed to probe the significance of alcohol and imine moieties tailored on a benzoin scaffold to better understand the structure activity relation (SAR) and improve their biological activity as anticancer compounds. Methods: Chemical synthesis of the targeted compounds, biological evaluation tests against human colon adenocarcinoma (HCT-116), breast adenocarcinoma (MCF-7), and breast carcinoma (T47D) cell lines, as well as Glide docking studies were employed in this investigation. Results: A new series of 1,2-diphenylimino ethanol was successfully synthesized and characterized by means of FT-IR, HRMS, NMR, and by elemental analysis. Biological screening revealed that the newly synthesized compounds inhibit PI3Kα activity in human colon adenocarcinoma (HCT-116), breast adenocarcinoma (MCF-7), and breast carcinoma (T47D) cell lines. Results additionally showed that these compounds exhibit selective antiproliferative activity, induce apoptosis, and suppress the VEGF production. Compounds 2b, 2d, and 2g displayed promising inhibitory activity in HCT-116 suggesting that hydrophobic and/or hydrogen bond-acceptor mediate(s) ligand-receptor interaction on o-and m-positions. Furthermore, compounds 2g, 2i, 2j, and 2h, bearing hydrophobic moiety on m-and p-position, exerted high antiproliferative activity in T47D and MCF-7 cells, whereas compound 2e showed selectivity against T47D and MCF-7. Molecular docking studies against PI3Kα and caspase-3 demonstrated a strong correlation between the predicted binding affinity (∆Gobsd) and IC50 values of prepared compounds for the caspase-3 model, implying that the cellulous inhibitory activity was caspase-3-dependent. Moreover, Glide docking against PI3Kα identified Ser774, Lys802, E849, V851, and Asp933 as key binding residues. Conclusion: The series exerted a potential PI3Kα inhibitory activity in human carcinoma cell lines expressing PI3Kα.",
keywords = "1,2-diphenylimino ethanol, Angiogenesis, Caspase-3, Glide docking, HCT-116, MCF-7, PI3Kα, T47D",
author = "Sabbah, {Dima A.} and Fatima Al-Tarawneh and Talib, {Wamidh H.} and Kamal Sweidan and Bardaweel, {Sanaa K.} and Eveen Al-Shalabi and Zhong, {Haizhen Andrew} and Sheikha, {Ghassan Abu} and Khalaf, {Reema Abu} and Mubarak, {Mohammad S.}",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/1573406414666180412160142",
language = "English (US)",
volume = "14",
pages = "695--708",
journal = "Medicinal Chemistry",
issn = "1573-4064",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - Benzoin schiff bases

T2 - Design, synthesis, and biological evaluation as potential antitumor agents

AU - Sabbah, Dima A.

AU - Al-Tarawneh, Fatima

AU - Talib, Wamidh H.

AU - Sweidan, Kamal

AU - Bardaweel, Sanaa K.

AU - Al-Shalabi, Eveen

AU - Zhong, Haizhen Andrew

AU - Sheikha, Ghassan Abu

AU - Khalaf, Reema Abu

AU - Mubarak, Mohammad S.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Phosphoinositide 3-kinase α (PI3Kα) is an attractive target for anticancer drug design. Objectives: Target compounds were designed to probe the significance of alcohol and imine moieties tailored on a benzoin scaffold to better understand the structure activity relation (SAR) and improve their biological activity as anticancer compounds. Methods: Chemical synthesis of the targeted compounds, biological evaluation tests against human colon adenocarcinoma (HCT-116), breast adenocarcinoma (MCF-7), and breast carcinoma (T47D) cell lines, as well as Glide docking studies were employed in this investigation. Results: A new series of 1,2-diphenylimino ethanol was successfully synthesized and characterized by means of FT-IR, HRMS, NMR, and by elemental analysis. Biological screening revealed that the newly synthesized compounds inhibit PI3Kα activity in human colon adenocarcinoma (HCT-116), breast adenocarcinoma (MCF-7), and breast carcinoma (T47D) cell lines. Results additionally showed that these compounds exhibit selective antiproliferative activity, induce apoptosis, and suppress the VEGF production. Compounds 2b, 2d, and 2g displayed promising inhibitory activity in HCT-116 suggesting that hydrophobic and/or hydrogen bond-acceptor mediate(s) ligand-receptor interaction on o-and m-positions. Furthermore, compounds 2g, 2i, 2j, and 2h, bearing hydrophobic moiety on m-and p-position, exerted high antiproliferative activity in T47D and MCF-7 cells, whereas compound 2e showed selectivity against T47D and MCF-7. Molecular docking studies against PI3Kα and caspase-3 demonstrated a strong correlation between the predicted binding affinity (∆Gobsd) and IC50 values of prepared compounds for the caspase-3 model, implying that the cellulous inhibitory activity was caspase-3-dependent. Moreover, Glide docking against PI3Kα identified Ser774, Lys802, E849, V851, and Asp933 as key binding residues. Conclusion: The series exerted a potential PI3Kα inhibitory activity in human carcinoma cell lines expressing PI3Kα.

AB - Background: Phosphoinositide 3-kinase α (PI3Kα) is an attractive target for anticancer drug design. Objectives: Target compounds were designed to probe the significance of alcohol and imine moieties tailored on a benzoin scaffold to better understand the structure activity relation (SAR) and improve their biological activity as anticancer compounds. Methods: Chemical synthesis of the targeted compounds, biological evaluation tests against human colon adenocarcinoma (HCT-116), breast adenocarcinoma (MCF-7), and breast carcinoma (T47D) cell lines, as well as Glide docking studies were employed in this investigation. Results: A new series of 1,2-diphenylimino ethanol was successfully synthesized and characterized by means of FT-IR, HRMS, NMR, and by elemental analysis. Biological screening revealed that the newly synthesized compounds inhibit PI3Kα activity in human colon adenocarcinoma (HCT-116), breast adenocarcinoma (MCF-7), and breast carcinoma (T47D) cell lines. Results additionally showed that these compounds exhibit selective antiproliferative activity, induce apoptosis, and suppress the VEGF production. Compounds 2b, 2d, and 2g displayed promising inhibitory activity in HCT-116 suggesting that hydrophobic and/or hydrogen bond-acceptor mediate(s) ligand-receptor interaction on o-and m-positions. Furthermore, compounds 2g, 2i, 2j, and 2h, bearing hydrophobic moiety on m-and p-position, exerted high antiproliferative activity in T47D and MCF-7 cells, whereas compound 2e showed selectivity against T47D and MCF-7. Molecular docking studies against PI3Kα and caspase-3 demonstrated a strong correlation between the predicted binding affinity (∆Gobsd) and IC50 values of prepared compounds for the caspase-3 model, implying that the cellulous inhibitory activity was caspase-3-dependent. Moreover, Glide docking against PI3Kα identified Ser774, Lys802, E849, V851, and Asp933 as key binding residues. Conclusion: The series exerted a potential PI3Kα inhibitory activity in human carcinoma cell lines expressing PI3Kα.

KW - 1,2-diphenylimino ethanol

KW - Angiogenesis

KW - Caspase-3

KW - Glide docking

KW - HCT-116

KW - MCF-7

KW - PI3Kα

KW - T47D

UR - http://www.scopus.com/inward/record.url?scp=85052870592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052870592&partnerID=8YFLogxK

U2 - 10.2174/1573406414666180412160142

DO - 10.2174/1573406414666180412160142

M3 - Article

C2 - 29651943

AN - SCOPUS:85052870592

VL - 14

SP - 695

EP - 708

JO - Medicinal Chemistry

JF - Medicinal Chemistry

SN - 1573-4064

IS - 7

ER -